These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4123412)

  • 1. Hazards of potent topical corticosteroids.
    Lancet; 1973 Apr; 1(7808):870-1. PubMed ID: 4123412
    [No Abstract]   [Full Text] [Related]  

  • 2. Side effects of potent topical corticosteroids.
    Jackson R
    Can Med Assoc J; 1978 Jan; 118(2):173-4. PubMed ID: 93507
    [No Abstract]   [Full Text] [Related]  

  • 3. Sid effects from topical corticosteroid therapy.
    Schöpf E
    Ann Clin Res; 1975 Dec; 7(6):353-67. PubMed ID: 129024
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical drug addiction: adverse effects of fluorinated corticosteroid creams and ointments.
    Burry JN
    Med J Aust; 1973 Feb; 1(8):393-6. PubMed ID: 4266903
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of atrophogenicity of popularly prescribed topical corticosteroids.
    Dykes PJ; Marks R; Blakemore CB
    Br J Clin Pract; 1978 Dec; 32(12):345-8. PubMed ID: 737113
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects and side-effects of locally administered corticosteroids].
    Rodermund OE
    Fortschr Med; 1975 Nov; 93(32):1600-6. PubMed ID: 130330
    [No Abstract]   [Full Text] [Related]  

  • 7. [The rational use of topical corticosteroids. New trends in long-term treatment].
    Garcovich A; Serri F
    Minerva Med; 1979 Sep; 70(39):2701-6. PubMed ID: 158145
    [No Abstract]   [Full Text] [Related]  

  • 8. [Topical glucocorticoid therapy].
    Petres J
    Hippokrates; 1975 Feb; 46(1):42-59. PubMed ID: 123522
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative animal experiments on epidermal hypoplasia induced by means of topical glucocorticoids].
    Weirich EG; Longauer J
    Z Hautkr; 1974 Feb; 49(3):91-106. PubMed ID: 4832936
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contact hypersensitivity and cross-reactions to topical corticosteroids].
    Milpied-Homsi B; Goossens A
    Ann Dermatol Venereol; 2001 Sep; 128(8-9):935-7. PubMed ID: 11590351
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible side effects of topical steroids.
    Morman MR
    Am Fam Physician; 1981 Feb; 23(2):171-4. PubMed ID: 6450525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Topical administration of corticosteroids and their adverse effects].
    Gschwandtner WR
    Wien Klin Wochenschr; 1973 Jan; 85(4):49-54. PubMed ID: 4684064
    [No Abstract]   [Full Text] [Related]  

  • 13. Skin atrophy of the eyelid induced by topical ophthalmic corticosteroids.
    Neittaanmäki H; Kontkanen M; Kallioinen M
    Acta Ophthalmol Scand; 1998 Jun; 76(3):372-3. PubMed ID: 9686858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Perioral dermatitis and other skin disorders following local application of fluoridated corticosteroids].
    Mali JH
    Ned Tijdschr Geneeskd; 1980 Jan; 124(1):2-7. PubMed ID: 6445510
    [No Abstract]   [Full Text] [Related]  

  • 15. Current dangers and problems in the topical use of steroids.
    Deakin MJ
    Med J Aust; 1976 Jan; 1(5):120-1. PubMed ID: 772378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
    Serup J; Holm P
    Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
    McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
    Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical corticosteroids and bullous pemphigoid.
    Hull CM; McKenna JK; Zone JJ
    Arch Dermatol; 2003 Feb; 139(2):225-6. PubMed ID: 12588236
    [No Abstract]   [Full Text] [Related]  

  • 19. The Duhring chamber assay for corticosteroid atrophy.
    Frosch PJ; Behrenbeck EM; Frosch K; Macher E
    Br J Dermatol; 1981 Jan; 104(1):57-65. PubMed ID: 7459270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrophy of the skin. The clinical problems.
    Sneddon IB
    Br J Dermatol; 1976 Mar; 94 suppl 12():121-3. PubMed ID: 1268072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.